Absence of QTc prolongation with cetirizine in children aged 6 to 11 years

Pediatric Asthma, Allergy and Immunology

Volumn 10, Issue 4, 1996, Pages 181-190

  Winder, John A ^a   Noonan, Michael J ^b   Lumry, William R ^c   Pearlman, David S ^d  

^a Allergy Asthma Research Ctr Toledo   (United States)

^b Allergy Associates PC   (United States)

^c Allergy And Asthma Research Associates Texas   (United States)

^d Respiratory Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE;

ABDOMINAL PAIN; ALLERGIC RHINITIS; ARTICLE; CHILD; CHRONIC URTICARIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; EPISTAXIS; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHARYNGITIS; PRIORITY JOURNAL; QT INTERVAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030435889     PISSN: 08831874     EISSN: None     Source Type: Journal    
DOI: 10.1089/pai.1996.10.181     Document Type: Article

References (33)

1. Turkeltaub PC, Gergen PJ. Prevalence of upper and lower respiratory conditions in the U.S. population by social and environmental factors: Data from the Second National Health and Nutrition Examination Survey, 1976 to 1980 (NHANES II). Ann Allergy 1996;67:147-154.
2. 1 antihistamines. J Allergy Clin Immunol 1990;86:1040-1046.
3. Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-2790.
4. Roden DM. Torsade de pointes. Clin Cardiol 1993;16:683-686.
5. Rao KA, Adlakha A, Verma-Ansil B, et al. Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994;69:589-593.
6. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-1536.
7. Pulmonary-Allergy Drugs Advisory Committee. Proceedings of the Pulmonary-Allergy Drugs Advisory Committee. Rockville, MD: U.S. Food and Drug Administration, Public Health Services, U.S. Department of Health and Human Services, 1990.
8. Yun C-H, Okerholm RA, Guengerich FP. Oxidation of the antihistaminic drug terfenadine in human liver microsomes: Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metab Dispos Biol Fate Chem 1993;21:403-409.
9. Peck CC, Temple R, Collins JM. Understanding consequences of concurrent therapies. JAMA 1993;269:1550-1552.
10. k, by terfenadine in cat ventricular myocytes [abstract]. J Am Coll Cardiol 1991;17:140A.
11. Chen Y, Woosley RL. Electrophysiologic actions of astemizole [abstract]. Clin Pharmacol Ther 1994;55:146.
12. c prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991;83:1888-1894.
13. Smith JM. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema). In Middleton E, Jr, Reed CE, Ellis EF, et al, eds. Allergy: Principles and Practice, 3rd ed. St. Louis: CV Mosby; 1988, pp 891-929.
14. Linna O, Kokkonen J, Lukin M. A 10-year prognosis for childhood allergic rhinitis. Acta Paediatr 1992;81:100-102.
15. Kaiser HB. Cetirizine in allergic rhinitis. Pediatr Allergy Immunol 1993;4(suppl 4):44-46.
16. Watson WTA, Simons KJ, Chen XY, Simons FER. Cetirizine: A pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:457-464.
17. Masi M, Candiani R, van de Venne H. A placebo-controlled trial of Cetirizine in seasonal allergic rhino-conjunctivitis in children aged 6 to 12 years. Pediatr Allergy Immunol 1993;4 (suppl 4):47-52.
18. Baelde Y, Dupont P. Cetirizine in children with chronic allergic rhinitis. A multicentre double-blind study of two doses of cetirizine and placebo. Drug Invest 1992;4:466-472.
19. Sale ME, Barbey JT, Woosley RL, et al. Pharmacodynamics and drug action. The electrocardiographic effects of cetirizine in normal subjects. Clin Pharmacol Ther 1994;56:295-301.
20. Hodges M, Salerno D, Erlien D. Bazett's QT correction reviewed: Evidence that a linear QT correction for heart rate is better [abstract]. J Am Coll Cardiol 1983;1:694.
21. c interval prolongation: A review. Am J Cardiol 1993;72:23B-25B.
22. Honig PK, Woosley RL, Zamani K, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-238.
23. Honig PK, Wortham DC, Zamani K, Conner DP, Mullin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-1518.
24. MacConnell TJ, Stanners AJ. Torsades de pointes complicating treatment with terfenadine [letter]. BMJ 1991;302:1469.
25. Simons FER, Kesselman MS, Giddins NG, et al. Astemizole-induced torsade de pointes. Lancet 1988;2:624.
26. Snook J, Boothman-Burrell D, Watkins J, Colin-Jones D. Torsade de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract 1988;42:257-259.
27. Craft TM. Torsade de pointes after astemizole overdose. BMJ 1986;292:660.
28. Honig P, Wortham D, Zamani K, et al. Comparison of the effect of macrolide antibiotics on terfenadine steady state pharmacokinetics and eletrocardiography parameters. Drug Investig 1994;7:148-156.
29. c [abstract]. Clin Pharmacol Ther 1994;146.
30. Woosley R, Darrow WR. Analysis of potential adverse drug reactions-A case of mistaken identity [letter]. Am J Cardiol 1994;74:208-209.
31. 14C-cetirizine in humans. Ann Allergy 1987;59(part II):31-34.
32. Sale M, Woosley R, Thakker K, et al. Effects of cetirizine and erythromycin alone and in combination on QT interval and pharmacokinetics in healthy subjects. Ann Allergy Asthma Immunol 1996;76:93.
33. Sale M, Woolsey R, Thakker K, et al. A randomized, placebo-controlled multiple dose study to evaluate the electrocardiographic and pharmacokinetic interactions of azithromycin and cetirizine. Ann Allergy Asthma Immunol 1996;76:93.